|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 432.3 DKK | +1.36% |
|
+3.32% | +16.49% |
| 05-10 | NOVONESIS : Key segments outperform in average Q1 24 showing |  |
| 05-03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 |
January 29, 2024 Company announcement No. 04 |
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
Please read the full announcement in PDF.
Attachment
| 1st Jan change | Capi. | |
|---|---|---|
| +16.49% | 28.87B | |
| -5.78% | 4.3B | |
| +14.70% | 1.83B | |
| -12.61% | 641M | |
| -13.17% | 463M | |
| -81.65% | 216M | |
| -12.94% | 113M | |
| -12.68% | 53.73M |
NOVONESIS A/S 
